Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 27, 2020 07:30 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Completes Divestment of Women’s Health Assets

Vyleesi® returned to Palatin Technologies Company focuses on optimizing marketed assets and development of its innovative pipeline WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- AMAG...
July 23, 2020 07:13 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Australia and New Zealand

Agreement provides AMAG with $30 million upfront payment and eligibility to receive up to $260 million in development and commercial milestones in addition to sales royalties ...
July 12, 2020 08:30 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Announces Presentation of Ciraparantag Data at the International Society on Thrombosis and Haemostasis

WALTHAM, Mass., July 12, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the poster presentation of data from two Phase 2 randomized, placebo-controlled, dose...
June 11, 2020 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Leadership Changes

Company initiates CFO & COO succession plan; appoints internal seasoned finance leader as interim CFO Anthony Casciano assumes expanded role as AMAG’s COO WALTHAM, Mass., June ...
May 27, 2020 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Participate in Jefferies Virtual Global Healthcare Conference

WALTHAM, Mass., May 27, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will participate at the Jefferies Virtual Global Healthcare Conference on...
May 21, 2020 17:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 Million

Transaction allows AMAG to advance its strategic focus on Feraheme, Makena and its pipeline, consistent with previously announced plans Millicent Pharma uniquely positioned to drive revenue growth of...
May 11, 2020 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update

Feraheme® (ferumoxytol injection) posts strong first quarter results Company implements a workforce reduction of approximately 30 percent or 140 positions, as part of a planned decrease in operating...
April 28, 2020 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Appoints Scott Myers as President and Chief Executive Officer

WALTHAM, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its Board of Directors has appointed Scott Myers as AMAG’s President and Chief...
April 27, 2020 16:30 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Host First Quarter 2020 Financial Results Conference Call and Webcast on Monday, May 11, 2020

WALTHAM, Mass., April 27, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its first quarter 2020 financial results will be released on Monday, May 11, 2020...
April 16, 2020 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Provides COVID-19 Company Update

WALTHAM, Mass., April 16, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today provided an update regarding the potential impact of COVID-19 on the company. AMAG is committed to...